Dale E. Bredesen
Dr. Dale E. Bredesen received an undergraduate degree from Caltech, medical degree from Duke, and served his residency and chief residency in Neurology at the University of California San Francisco (UCSF). Prior to joining the UCLA faculty, where he was recruited by the Burnham Institute to direct the Program on Aging, he earned a postdoctoral fellowship in the laboratory of Nobel laureate professor Stanley Prusiner.
Dr. Dale founded the Buck Institute for Research on Aging. He also served as Adjunct Professor at UCSF before returning to UCLA to direct the Easton Center for Alzheimer’s Disease Research, and as professor of molecular and medical pharmacology at the David Geffen School of Medicine.
Dale has published over 220 research papers, established the Alzheimer’s Drug Development Network (ADDN), and with his group developed a new approach to disease treatment. For five months his book, The End of Alzheimer’s, was on the New York Times Bestsellers List.